Anna D'angelillo
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohort.
Journal: Antiviral therapy
Published: December 19, 2024
HIV and vicarious stigma in a cohort of people living with HIV in Italy: What happens when the stigma is fueled by healthcare providers?
Journal: AIDS care
Published: June 04, 2024
Two-Drug Regimen Containing Darunavir: Metabolic Evaluation of an Old Dual Therapy.
Journal: AIDS research and human retroviruses
Published: July 06, 2023
Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life.
Journal: AIDS research and human retroviruses
Published: September 27, 2022
Evaluation of doravirine-based regimen population target in a large Italian clinical center.
Journal: Antiviral therapy
Published: April 29, 2022
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice.
Journal: Journal of medical virology
Published: March 01, 2022
Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 16, 2021
Viral Encephalitis in Adults: A Narrative Review.
Journal: Reviews on recent clinical trials
Published: April 16, 2021
Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice.
Journal: AIDS research and human retroviruses
Published: December 07, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026